• Profile
Close

The effect of menopause on metabolic syndrome: Cross-sectional results from the Canadian longitudinal study on aging

Menopause Aug 31, 2020

Christakis MK, Hasan H, De Souza LR, et al. - In order to evaluate whether menopause is an independent risk factor for the development of metabolic syndrome (MetS) or its components, including hypertension, central obesity, dyslipidemia, or elevated glycated hemoglobin, researchers here examined data from women surveyed in the Canadian Longitudinal Study on Aging. They performed a cross-sectional analysis of 12,611 women (aged 45-85 years old) that participated in the baseline data of the Canadian Longitudinal Study on Aging Comprehensive Cohort collected from 2012 to 2015. Among these women, 10,035 (79.6%) had undergone menopause and 2,576 (20.4%) were premenopausal. Criteria for MetS were more frequently met by postmenopausal women vs premenopausal women (32.6% vs 20.5%). Findings thereby indicate an increased risk of MetS in correlation with menopause, independent of age. Preventive effects of lifestyle interventions targeted at women with MetS on type 2 diabetes mellitus and cardiovascular risk are suggested. They suggest perimenopause to be a significant preventative care opportunity to determine metabolic risk factors and improve health and longevity of Canadian women.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay